Mergers & Acquisitions

By The Online Investor Staff, updated Sat., Sep. 19, 8:43 AM

This Slide: #13 of 100

Slide #13. Enzolytics, Inc. — BioClonetics Immunotherapeutics, Inc.

Acquirer:	Enzolytics, Inc. (ENZC)
Acquiree:	BioClonetics Immunotherapeutics, Inc.
Details:	Enzolytics, Inc. (OTC PINK:ENZC or the "Company") today announced the execution of a non-binding letter of intent (the "LOI") to merge with BioClonetics Immunotherapeutics, Inc. ("BCLS" or "BioClonetics") a biotech company located in Dallas Texas.

Enzolytics, Inc.: ENZC
BioClonetics Immunotherapeutics, Inc. : PRIVATE

« Back to slide 12

Continue to slide 14 »

Open the YDX.CA Page at The Online Investor (in a new window) »

YDX.CA — Current Quote

Quotes delayed 20 minutes

Mergers & Acquisitions Page | www.TheOnlineInvestor.com

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.